The recent surge inthe demand of radiopharmaceuticals for diagnostic and therapeutic applications,coupled with the introduction of theranostics, has opened up opportunities forcompanies having capabilities to manufacture nuclear medicine and radiopharmaceuticals
Roots Analysis is pleased toannounce the publication of its recent study, titled, “NuclearMedicine and Radiopharmaceuticals ManufacturingMarket, 2020-2030”
The report provides adetailed study on the current market landscape and future potential of thecompanies having the capabilities to manufacture radiopharmaceuticals. Inaddition, the study features an in-depth analysis, highlighting thecapabilities of a diverse set of industry stakeholders. Amongst other elements,the report features the following:
§ A detailed assessment of the current market landscape withrespect to the players (industry and non-industry) involved in manufacturingradiopharmaceuticals.
§ An insightful four-dimensional comparison of theradiopharmaceutical manufacturers.
§ Tabulated profiles of key industry players based in NorthAmerica, Europe and Asia-Pacific (shortlisted based on the company size of theplayers).
§ An analysis of recent partnerships and collaborations inkedin this domain since 2017.
§ A detailed discussion on the supply chain model of medicalisotope Mo-99 (Tc-99m).
§ A detailed market forecast, featuring analysis of thecurrent and projected future opportunity across key market segments (listedbelow)
§ Target Therapeutic Area
§ Cardiology
§ Neurology
§ Oncology
§ Thyroid
§ Others
- Application Area
§ Diagnostic
§ Therapeutic
§ Type of Diagnostic Radiopharmaceuticals
§ PET
§ SPECT
§ Type of Therapeutic Radiopharmaceuticals
§ Alpha Emitters
§ Beta Emitters
§ Others
§ Purpose of Production
§ In-House
§ Outsourcing
- Key Geographical Region
§ North America
§ Europe
§ Asia-Pacific and theRest of the World
Transcriptsof interviews held with the following senior level representatives ofstakeholder companies
§ J JamesDavis, Vice President Quality / R&D, Shertech Laboratories
§ AndreasFotopoulos, Professor of Nuclear Medicine, University of Ioannina MedicalSchool
§ JanPruim, Professor of Medical Imaging / Nuclear Medicine Physician, UniversityMedical Center of Groningen
§ Michaelvan Dam, Professor, Crump Institute for Molecular Imaging, Molecular &Medical Pharmacology
§ Anonymous, ITMIsotopen Technologien München
Keycompanies covered in the report
§ Advanced AcceleratorApplications
§ Belgian NuclearResearch Center (SCK•CEN)
§ Cardinal Health
§ China Isotope &Radiation Corporation
§ Curium Pharma
§ DuChemBio
§ Eckert & Ziegler
§ Eczacibasi-Monrol
§ GE Healthcare
§ Jubilant DraxImage
§ Lantheus MedicalImaging
§ Nihon Medi-Physics
§ Nordion
§ PETNET Solutions
§ SinoTauPharmaceuticals
§ SOFIE
Formore information please click on the following link:
https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html
Other RecentOfferings
1. High Energy Chemistry / Hazardous Chemistry-based APIManufacturing ServicesMarket: Focus on High Temperature, Low Temperature / Cryogenic, High Pressureand Low Pressure Chemistries, 2020-2030
2. Live Biotherapeutic Products and Microbiome ContractManufacturing Market: Focus on Active PharmaceuticalIngredients and Finished Dosage Forms,2020-2030
3. China Biopharmaceutical Contract Manufacturing Market, 2020 - 2030
4. ContinuousManufacturing Market (Small Molecules and Biologics), 2020 – 2030
About Roots Analysis
Roots Analysis is one of the fastest growingmarket research companies, sharing fresh and independent perspectives in the bio-pharmaceuticalindustry. The in-depth research, analysis and insights are driven by anexperienced leadership team which has gained many years of significantexperience in this sector. If you’d like help with your growing business needs,get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
